简体中文
|
English
HOME
ABOUT US
Introduction
Company Culture
Management Team
RESEARCH CENTER
Product Pipelines
ADC Technology
NEWS AND MEDIA
CAREERS
CONTACT US
HOME
ABOUT US
RESEARCH CENTER
NEWS AND MEDIA
CAREERS
CONTACT US
NEWS AND MEDIA
Home
NEWS AND MEDIA
2018.07.26
MRG001 IND application formally accepted by CDE
07/13
2018
Shanghai Miracogen raised 350 million RMB in series A
06/04
2018
Shanghai Miracogen in-licensed an ADC from Fudan University and SIMM (Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
05/28
2018
MRG002 IND approved by CFDA
05/09
2018
First patient dosed with MRG003 in the phase I clinical study at SUN YAT-SEN University Cancer Center
11/06
2017
MRG002 IND application formally accepted by CDE
FIRST
previous page
1
2
3
4
next page
END
